Company profile for Eyevance Pharmaceuticals LLC

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

We’re always working to identify unique collaborative opportunities in the ophthalmic space and have the experience and agility to execute. Eyevance Pharmaceuticals was founded in September 2017 by Jerry St. Peter and Jason Werner. As accomplished entrepreneurs with ophthalmic expertise, their track record of success with both established and vanguard pharmacological products informs the company’s direction. Based in Fort ...
We’re always working to identify unique collaborative opportunities in the ophthalmic space and have the experience and agility to execute. Eyevance Pharmaceuticals was founded in September 2017 by Jerry St. Peter and Jason Werner. As accomplished entrepreneurs with ophthalmic expertise, their track record of success with both established and vanguard pharmacological products informs the company’s direction. Based in Fort Worth, Texas, the Eyevance team has established working relationships with key opinion leaders (KOLs) whose industry knowledge spans from the clinic to the classroom at most ophthalmic institutions in the United States.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
777 Taylor Street, Suite 1050 Fort Worth, TX 76102
Telephone
Telephone
(817) 677-6120
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.investegate.co.uk/clinigen-group-plc--clin-/rns/clinigen-signs-exclusive-agreement-with-eyevance/202108050700066262H/

INVESTEGATE3
05 Aug 2021

https://www.prnewswire.com/news-releases/eyevance-pharmaceuticals-acquires-tobradex-st-and-natacyn-300939668.html

PR NEWSWIRE
17 Oct 2019

https://www.prnewswire.com/news-releases/eyevance-pharmaceuticals-executes-strategic-transaction-300737063.html

PR NEWSWIRE
24 Oct 2018

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty